These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 27096250)
1. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters. Milosheska D; Lorber B; Vovk T; Kastelic M; Dolžan V; Grabnar I Br J Clin Pharmacol; 2016 Aug; 82(2):399-411. PubMed ID: 27096250 [TBL] [Abstract][Full Text] [Related]
2. Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients. Singkham N; Towanabut S; Lertkachatarn S; Punyawudho B Eur J Clin Pharmacol; 2013 Jun; 69(6):1285-91. PubMed ID: 23263737 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling. Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733 [TBL] [Abstract][Full Text] [Related]
4. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy. Wang ML; Tao YY; Sun XY; Guo Y; Wang ZY; Cao YF; Zhao L Pharmacol Res; 2021 Jul; 169():105610. PubMed ID: 33857625 [TBL] [Abstract][Full Text] [Related]
5. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine. Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295 [TBL] [Abstract][Full Text] [Related]
6. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children. Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens. Lin WW; Li XW; Jiao Z; Zhang J; Rao X; Zeng DY; Lin XH; Wang CL Eur J Clin Pharmacol; 2019 Mar; 75(3):381-392. PubMed ID: 30456415 [TBL] [Abstract][Full Text] [Related]
8. Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy. Inoue K; Yamamoto Y; Suzuki E; Takahashi T; Umemura A; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K Eur J Clin Pharmacol; 2016 May; 72(5):555-62. PubMed ID: 26790665 [TBL] [Abstract][Full Text] [Related]
9. Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy. Klarica Domjanović I; Lovrić M; Trkulja V; Petelin-Gadže Ž; Ganoci L; Čajić I; Božina N Br J Clin Pharmacol; 2018 Sep; 84(9):2106-2119. PubMed ID: 29791014 [TBL] [Abstract][Full Text] [Related]
10. A Population Pharmacokinetic-Pharmacogenetic Model of Lamotrigine in Chinese Children With Epilepsy. Chen Y; Xu S; Wang Z; Zhao M; Wang H; Lu T; Zhao L Ther Drug Monit; 2018 Dec; 40(6):730-737. PubMed ID: 30169477 [TBL] [Abstract][Full Text] [Related]
11. Influence of UGT2B7, UGT1A4 and ABCG2 Polymorphisms on the Pharmacokinetics and Therapeutic Efficacy of Lamotrigine in Patients with Epilepsy. Yang J; Wang J; Ning L; Wu C; Liu Y; Xia J; Guan Y; Liu Q; Zheng J Eur J Drug Metab Pharmacokinet; 2024 Jul; 49(4):437-447. PubMed ID: 38709450 [TBL] [Abstract][Full Text] [Related]
12. Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients. Petrenaite V; Öhman I; Jantzen FPT; Ekström L Epilepsy Res; 2022 May; 182():106897. PubMed ID: 35303539 [TBL] [Abstract][Full Text] [Related]
13. Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy. Božina N; Sporiš IŠ; Domjanović IK; Ganoci L; Šimičević L; Lovrić M; Romić ZČ; Gadže ŽP; Trkulja V Eur J Clin Pharmacol; 2023 Aug; 79(8):1117-1129. PubMed ID: 37340142 [TBL] [Abstract][Full Text] [Related]
14. Impact of UGT1A4 and UGT2B7 polymorphisms on lamotrigine plasma concentration in patients with bipolar disorder. Zhao T; Zhang HL; Feng J; Cui L; Sun L; Li HJ; Yu LH Pharmacogenet Genomics; 2024 Oct; 34(8):261-267. PubMed ID: 39171428 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. Hussein Z; Posner J Br J Clin Pharmacol; 1997 May; 43(5):457-65. PubMed ID: 9159559 [TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetics of Lamotrigine and Its N2-Glucuronide Metabolite in Chinese Patients With Epilepsy. Yang H; Zhang D; Wei S; Zhao Z; Mei S Ther Drug Monit; 2024 Oct; 46(5):649-657. PubMed ID: 38666475 [TBL] [Abstract][Full Text] [Related]
17. The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy. Gulcebi MI; Ozkaynakcı A; Goren MZ; Aker RG; Ozkara C; Onat FY Epilepsy Res; 2011 Jun; 95(1-2):1-8. PubMed ID: 21601426 [TBL] [Abstract][Full Text] [Related]
18. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy. Wang Q; Liang M; Dong Y; Yun W; Qiu F; Zhao L; Guo Y Drug Metab Pharmacokinet; 2015 Jun; 30(3):209-13. PubMed ID: 25922177 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients. Zhou Y; Wang X; Li H; Zhang J; Chen Z; Xie W; Zhang J; Li J; Zhou L; Huang M Drug Metab Pharmacokinet; 2015 Aug; 30(4):282-7. PubMed ID: 26213157 [TBL] [Abstract][Full Text] [Related]